FDA 483 - Svelte Medical Systems, Inc. - June 14, 2021
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Svelte Medical Systems in New Providence, NJ, was inspected and received a Form FDA 483 with five observations. The inspection revealed significant issues with design control documentation, including inadequately defined design outputs and insufficient documentation of design risk analysis results for their drug-eluting coronary stent system. Additionally, the firm's quality system procedures for corrective and preventive actions, management reviews, and device history records were found to be deficient.
- Person
ID · 297be647-cbac-410a-be62-98f73715cbd1